This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Zajecka, John
| Item Type | Name |
|
Concept
|
Dose-Response Relationship, Drug
|
|
Academic Article
|
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
|
|
Academic Article
|
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Evidence for the use of l-methylfolate combined with antidepressants in MDD.
|
|
Academic Article
|
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
|
|
Academic Article
|
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
|
|
Academic Article
|
CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
|
|
Academic Article
|
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
|
|
Academic Article
|
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
|
|
Academic Article
|
Six-year perspectives on the safety and tolerability of nefazodone.
|
|
Academic Article
|
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.
|
- Dose Response Relationship Drug